D. E. Shaw & Co., Inc. - ATHIRA PHARMA INC ownership

ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 84 filers reported holding ATHIRA PHARMA INC in Q1 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of ATHIRA PHARMA INC
ValueSharesWeighting
Q3 2023$60,699
-59.5%
30,049
-40.8%
0.00%
Q2 2023$149,766
-5.6%
50,768
-20.0%
0.00%
Q1 2023$158,685
-67.1%
63,474
-58.3%
0.00%
-100.0%
Q4 2022$482,297
+26.6%
152,144
+18.7%
0.00%
Q3 2022$381,000
+495.3%
128,122
+511.3%
0.00%
Q2 2022$64,000
-71.3%
20,960
+26.9%
0.00%
Q1 2022$223,000
-68.1%
16,522
-69.2%
0.00%
-100.0%
Q4 2021$700,00053,7000.00%
Other shareholders
ATHIRA PHARMA INC shareholders Q1 2023
NameSharesValueWeighting ↓
VR Adviser, LLC 1,691,623$57,938,0008.52%
ACUTA CAPITAL PARTNERS, LLC 393,000$13,460,0003.66%
Logos Global Management LP 947,873$32,465,0002.78%
RTW INVESTMENTS, LP 2,685,779$88,899,0001.49%
Avidity Partners Management LP 1,043,873$35,753,0001.16%
Perceptive Advisors 3,114,805$106,682,0001.14%
Sofinnova Investments, Inc. 509,168$17,439,0001.04%
HighVista Strategies LLC 32,062$1,098,0000.70%
Rock Springs Capital Management LP 860,902$29,486,0000.62%
PFM Health Sciences, LP 470,227$16,105,0000.57%
View complete list of ATHIRA PHARMA INC shareholders